Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Current status: In 2024, the FDA removed TB-500 from 503B outsourcing facility compounding
MT-1 is used in comparative receptor subtype selectivity research alongside Melanotan II, native -MSH, PT-141, and receptor subtype-selective agonists and antagonists and characterising how the Nle4/D-Phe7 modification pattern determines receptor subtype binding affinity ratios across MC1R through MC5R and examining how these binding selectivity differences translate into differential biological outputs in tissues expressing different melanocortin receptor subtype combinations
Notably, UBR5 ubiquitylation of wild-type OTUD5 was less effective than that of C224R OTUD5 (Fig
Some are athletes recovering from a specific injury who also want to improve their skin
US$ 25.51
US$ 27.65
US$ 23.92
US$ 20.44
US$ 29.15
US$ 22.08
US$ 27.11
US$ 21.52
US$ 20.80
